Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 1
2006 6
2007 4
2008 5
2009 4
2010 3
2011 1
2013 5
2014 4
2015 2
2016 3
2017 4
2018 3
2019 2
2020 6
2021 11
2022 6
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean zhijun zhen (1 results)?
Treatment Outcome of Response-Based Radiation Therapy in Children and Adolescents With Central Nervous System Nongerminomatous Germ Cell Tumors: Results of a Prospective Study.
Zeng C, Yang Q, Li Z, Wei Z, Chen T, Deng M, Wang J, Wang J, Sun F, Huang J, Lu S, Zhu J, Sun X, Zhen Z. Zeng C, et al. Among authors: zhen z. Int J Radiat Oncol Biol Phys. 2023 Dec 18:S0360-3016(23)08235-4. doi: 10.1016/j.ijrobp.2023.12.006. Online ahead of print. Int J Radiat Oncol Biol Phys. 2023. PMID: 38122991
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group.
Huang DP, Yang LC, Chen YQ, Wan WQ, Zhou DH, Mai HR, Li WL, Yang LH, Lan HK, Chen HQ, Guo BY, Zhen ZJ, Liu RY, Chen GH, Feng XQ, Liang C, Wang LN, Li Y, Luo JS, Fan Z, Luo XQ, Li B, Tang YL, Zhang XL, Huang LB. Huang DP, et al. Blood Cancer J. 2023 Dec 5;13(1):178. doi: 10.1038/s41408-023-00949-w. Blood Cancer J. 2023. PMID: 38052803 Free PMC article. Clinical Trial.
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China.
Hong Y, Song M, Lan Y, Wang J, Lu S, Zhang Y, Zhu J, Sun F, Huang J, Liu J, Xu J, Wu Y, Guo H, Cai R, Zhen Z, Que Y, Zhang Y. Hong Y, et al. Among authors: zhen z. Front Immunol. 2023 Jun 9;14:1182751. doi: 10.3389/fimmu.2023.1182751. eCollection 2023. Front Immunol. 2023. PMID: 37359533 Free PMC article.
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.
Huang J, Lu S, Wang J, Jiang L, Luo X, He X, Wu Y, Wang Y, Zhu X, Chen J, Tang Y, Chen K, Tian X, Shi B, Guo L, Zhu J, Sun F, Zhen Z, Zhang Y. Huang J, et al. Among authors: zhen z. Cancer Med. 2023 Jul;12(13):14130-14137. doi: 10.1002/cam4.6079. Epub 2023 May 15. Cancer Med. 2023. PMID: 37183837 Free PMC article. Clinical Trial.
82 results